Add to ORKGAustralian National Health and Medical Research CouncilMRCBritish Heart Foundation
Background: Current evidence from randomized controlled trials on statins for primary prevention of ...
Background: There is limited evidence on statin risk and effectiveness for patients aged 80+. We es...
Objectives To investigate whether statins reduce all cause mortality and major coronary and cerebrov...
Background: Statin therapy has been shown to reduce major vascular events and vascular mortality in ...
Background Statin therapy has been shown to reduce major vascular events and vascular mortality in a...
Background. Statin therapy significantly reduces cardiovascular events. Older patients, however, are...
Statins are one of the most heavily prescribed medications. The 2018 ACC/AHA guidelines support stat...
ObjectivesThis study was designed to determine whether statins reduce all-cause mortality in elderly...
AbstractObjectivesThis study evaluated the effect of statin therapy on mortality in individuals with...
Objective Statins have been shown to be beneficial for the prevention of cardiovascular events. In e...
OBJECTIVE: Assess whether statins reduce mortality in the general population aged 60 years and above...
BACKGROUND: There is limited evidence on statin risk and effectiveness for patients aged 80+. We est...
OBJECTIVES: The purpose of this paper was to assess whether statins reduce all-cause mortality and ...
OBJECTIVE — Rates of cardiovascular disease are highest in the elderly. Lipid-lowering statin therap...
Rates of cardiovascular disease are highest in the elderly. Lipid-lowering statin therapy reduces th...
Background: Current evidence from randomized controlled trials on statins for primary prevention of ...
Background: There is limited evidence on statin risk and effectiveness for patients aged 80+. We es...
Objectives To investigate whether statins reduce all cause mortality and major coronary and cerebrov...
Background: Statin therapy has been shown to reduce major vascular events and vascular mortality in ...
Background Statin therapy has been shown to reduce major vascular events and vascular mortality in a...
Background. Statin therapy significantly reduces cardiovascular events. Older patients, however, are...
Statins are one of the most heavily prescribed medications. The 2018 ACC/AHA guidelines support stat...
ObjectivesThis study was designed to determine whether statins reduce all-cause mortality in elderly...
AbstractObjectivesThis study evaluated the effect of statin therapy on mortality in individuals with...
Objective Statins have been shown to be beneficial for the prevention of cardiovascular events. In e...
OBJECTIVE: Assess whether statins reduce mortality in the general population aged 60 years and above...
BACKGROUND: There is limited evidence on statin risk and effectiveness for patients aged 80+. We est...
OBJECTIVES: The purpose of this paper was to assess whether statins reduce all-cause mortality and ...
OBJECTIVE — Rates of cardiovascular disease are highest in the elderly. Lipid-lowering statin therap...
Rates of cardiovascular disease are highest in the elderly. Lipid-lowering statin therapy reduces th...
Background: Current evidence from randomized controlled trials on statins for primary prevention of ...
Background: There is limited evidence on statin risk and effectiveness for patients aged 80+. We es...
Objectives To investigate whether statins reduce all cause mortality and major coronary and cerebrov...